Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer

Clinical trial NCT04337970 · COMPLETED

Trial details

NCT number: NCT04337970
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Kidney Cancer Renal Cell Carcinoma Unresectable Renal Cell Carcinoma Metastatic Renal Cell Carcinoma

Start date: 2020-04-06
Primary completion: 2025-05-23
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.